BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 32178619)

  • 1. Human Mesenchymal Stem Cells for Spinal Cord Injury.
    Alishahi M; Anbiyaiee A; Farzaneh M; Khoshnam SE
    Curr Stem Cell Res Ther; 2020; 15(4):340-348. PubMed ID: 32178619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.
    Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A
    Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial Cell Line-Derived Neurotrophic Factor-Transfected Placenta-Derived Versus Bone Marrow-Derived Mesenchymal Cells for Treating Spinal Cord Injury.
    Lu Y; Gao H; Zhang M; Chen B; Yang H
    Med Sci Monit; 2017 Apr; 23():1800-1811. PubMed ID: 28408732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Anti-Inflammatory Effects of Mouse Adipose- and Bone-Marrow-Derived Multilineage-Differentiating Stress-Enduring Cells in Acute-Phase Spinal Cord Injury.
    Nagaoki T; Kumagai G; Nitobe Y; Sasaki A; Fujita T; Fukutoku T; Saruta K; Tsukuda M; Asari T; Wada K; Dezawa M; Ishibashi Y
    J Neurotrauma; 2023 Dec; 40(23-24):2596-2609. PubMed ID: 37051701
    [No Abstract]   [Full Text] [Related]  

  • 5. A combination of mesenchymal stem cells and scaffolds promotes motor functional recovery in spinal cord injury: a systematic review and meta-analysis.
    Yousefifard M; Nasseri Maleki S; Askarian-Amiri S; Vaccaro AR; Chapman JR; Fehlings MG; Hosseini M; Rahimi-Movaghar V
    J Neurosurg Spine; 2019 Nov; 32(2):269-284. PubMed ID: 31675724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Unique Properties of Placental Mesenchymal Stromal Cells: A Novel Source of Therapy for Congenital and Acquired Spinal Cord Injury.
    Kulubya ES; Clark K; Hao D; Lazar S; Ghaffari-Rafi A; Karnati T; Ebinu JO; Zwienenberg M; Farmer DL; Wang A
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bone marrow derived mesenchymal stromal cells and Schwann-like cells transplantation on spinal cord injury in adult male albino rats.
    Galhom RA; Hussein Abd El Raouf HH; Mohammed Ali MH
    Biomed Pharmacother; 2018 Dec; 108():1365-1375. PubMed ID: 30372839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs.
    Ryu HH; Kang BJ; Park SS; Kim Y; Sung GJ; Woo HM; Kim WH; Kweon OK
    J Vet Med Sci; 2012 Dec; 74(12):1617-30. PubMed ID: 22878503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury.
    Kim Y; Jo SH; Kim WH; Kweon OK
    Stem Cell Res Ther; 2015 Nov; 6():229. PubMed ID: 26612085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-bladder wall transplantation of bone marrow mesenchymal stem cells improved urinary bladder dysfunction following spinal cord injury.
    Salehi-Pourmehr H; Rahbarghazi R; Mahmoudi J; Roshangar L; Chapple CR; Hajebrahimi S; Abolhasanpour N; Azghani MR
    Life Sci; 2019 Mar; 221():20-28. PubMed ID: 30735734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Transplantation of Human Umbilical Cord Mesenchymal Stem Cells and Human Neural Stem Cells Improves the Outcome in Rats with Spinal Cord Injury.
    Sun L; Wang F; Chen H; Liu D; Qu T; Li X; Xu D; Liu F; Yin Z; Chen Y
    Cell Transplant; 2019 Jul; 28(7):893-906. PubMed ID: 31012325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Effects of Suppression of MicroRNA-383 in Human Bone-Marrow-Derived Mesenchymal Stem Cells on Treating Spinal Cord Injury.
    Wei GJ; Zheng KW; An G; Shi ZW; Wang KF; Guan Y; Wang YS; Li PF; Dong DM
    Cell Physiol Biochem; 2018; 47(1):129-139. PubMed ID: 29763918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult bone marrow mesenchymal and neural crest stem cells are chemoattractive and accelerate motor recovery in a mouse model of spinal cord injury.
    Neirinckx V; Agirman G; Coste C; Marquet A; Dion V; Rogister B; Franzen R; Wislet S
    Stem Cell Res Ther; 2015 Nov; 6():211. PubMed ID: 26530515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of Neurotrophic Effects of Mesenchymal Stem Cells Derived from Different Tissues on Chronic Spinal Cord Injury Rats.
    Otsuka T; Maeda Y; Kurose T; Nakagawa K; Mitsuhara T; Kawahara Y; Yuge L
    Stem Cells Dev; 2021 Sep; 30(17):865-875. PubMed ID: 34148410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of MicroRNA-383 Enhances Therapeutic Potential of Human Bone-Marrow-Derived Mesenchymal Stem Cells in Treating Spinal Cord Injury via GDNF.
    Wei GJ; An G; Shi ZW; Wang KF; Guan Y; Wang YS; Han B; Yu EM; Li PF; Dong DM; Wang LP; Teng ZW; Zhao DL
    Cell Physiol Biochem; 2017; 41(4):1435-1444. PubMed ID: 28365701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury.
    Zhou Z; Chen Y; Zhang H; Min S; Yu B; He B; Jin A
    Cytotherapy; 2013 Apr; 15(4):434-48. PubMed ID: 23376106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stem Cell Therapy for Spinal Cord Contusion: A Comparative Study on Small and Large Animal Models.
    Mukhamedshina Y; Shulman I; Ogurcov S; Kostennikov A; Zakirova E; Akhmetzyanova E; Rogozhin A; Masgutova G; James V; Masgutov R; Lavrov I; Rizvanov A
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31805639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of miR-10a-5p in bone marrow mesenchymal stem cells enhances the therapeutic effect on spinal cord injury via BDNF.
    Zhang T; Liu C; Chi L
    Neurosci Lett; 2020 Jan; 714():134562. PubMed ID: 31626878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury.
    Bydon M; Dietz AB; Goncalves S; Moinuddin FM; Alvi MA; Goyal A; Yolcu Y; Hunt CL; Garlanger KL; Del Fabro AS; Reeves RK; Terzic A; Windebank AJ; Qu W
    Mayo Clin Proc; 2020 Feb; 95(2):406-414. PubMed ID: 31785831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells.
    Xiao Z; Tang F; Zhao Y; Han G; Yin N; Li X; Chen B; Han S; Jiang X; Yun C; Zhao C; Cheng S; Zhang S; Dai J
    Cell Transplant; 2018 Jun; 27(6):907-915. PubMed ID: 29871514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.